Diagnostic Value of Endoscopic Narrow-Band Imaging Technique in Early Gastric Cancer and Precancerous Lesions.

The study addresses an established diagnostic question (NBI vs white-light endoscopy) and appears to replicate a known direction of effect, so its advance is incremental. Internal inconsistencies in the reported distributions limit its utility as a reliable additional data point.

Methods describe random allocation and histopathology as reference standard, but key reporting deficiencies and internal contradictions reduce confidence in execution (Abstract vs Results §3.2–§3.3) and suggest potential verification/workup bias via targeted biopsy language (Methods §2.2). Because reliability is Red, the craft score is capped at 2.0 (uncapped merit estimate 2.2).

The paper’s structure is recognizable, but comprehension is substantially impaired by repeated disease-term substitution ("leukemia") and contradictory group counts that a reader cannot reconcile from the narrative alone. The conclusion also overreaches toward broad clinical use without bounds.

Background and discussion include standard framing (Correa cascade, NBI optics rationale, VS classification) and cite prior studies, supporting basic contextual grounding. However, engagement with diagnostic-accuracy reporting norms and limitations is not developed, reducing contextual interpretability.

The target use case is clear—improving endoscopic detection of precancerous lesions and early gastric cancer in symptomatic patients—indicating a plausible clinical audience. The paper does not link findings to a specific guideline, program, or implementation decision point.

The intervention is an existing clinical imaging modality applied in a routine endoscopy workflow, placing the work in applied clinical validation rather than early-stage invention. The single-centre, internally inconsistent reporting prevents the study from being practice-changing evidence.

Generalizability is limited by a single-hospital sample (n=100) with sparse boundary-condition reporting beyond basic demographics. The internal inconsistencies in reported counts further reduce confidence that performance estimates would hold across settings.

The work aligns with a long-running research trajectory on NBI/VS classification for gastric neoplasia detection and could, in principle, contribute incremental evidence. However, unclear data integrity and limited methodological reporting reduce its value for cumulative synthesis.